about
Collaborative development of predictive toxicology applications.Investigation of substituent effect of 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides on CCR5 binding affinity using QSAR and virtual screening techniquesA novel QSAR model for predicting the inhibition of CXCR3 receptor by 4-N-aryl-[1,4] diazepane ureasOptimization of biaryl piperidine and 4-amino-2-biarylurea MCH1 receptor antagonists using QSAR modeling, classification techniques and virtual screeningComparative study of the AT₁ receptor prodrug antagonist candesartan cilexetil with other sartans on the interactions with membrane bilayers.Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL).Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches.Ligand and structure based virtual screening strategies for hit-finding and optimization of hepatitis C virus (HCV) inhibitors.Searching for Novel Janus Kinase-2 Inhibitors Using a Combination of Pharmacophore Modeling, 3D-QSAR Studies and Virtual Screening.Development of a Predictive Pharmacophore Model and a 3D-QSAR Study for an in silico Screening of New Potent Bcr-Abl Kinase Inhibitors.Molecular modeling on pyrimidine-urea inhibitors of TNF-α production: an integrated approach using a combination of molecular docking, classification techniques, and 3D-QSAR CoMSIA.Searching for anthranilic acid-based thumb pocket 2 HCV NS5B polymerase inhibitors through a combination of molecular docking, 3D-QSAR and virtual screening.Exploiting ChEMBL database to identify indole analogs as HCV replication inhibitors.MouseTox: An online toxicity assessment tool for small molecules through Enalos Cloud platform.Rational design, efficient syntheses and biological evaluation of N,N'-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers.In silico exploration for identifying structure-activity relationship of MEK inhibition and oral bioavailability for isothiazole derivatives.A novel simple QSAR model for the prediction of anti-HIV activity using multiple linear regression analysis.A combined LS-SVM & MLR QSAR workflow for predicting the inhibition of CXCR3 receptor by quinazolinone analogs.Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts.Consensus Predictive Model for Human K562 Cell Growth Inhibition through Enalos Cloud Platform.Computational toxicology: From cheminformatics to nanoinformatics.Identification of a series of novel derivatives as potent HCV inhibitors by a ligand-based virtual screening optimized procedure.Design and synthesis of novel quinolinone-3-aminoamides and their alpha-lipoic acid adducts as antioxidant and anti-inflammatory agents.A novel RBF neural network training methodology to predict toxicity to Vibrio fischeri.A novel QSAR model for predicting induction of apoptosis by 4-aryl-4H-chromenes.A novel QSPR model for predicting θ (lower critical solution temperature) in polymer solutions using molecular descriptors.Prediction of toxicity using a novel RBF neural network training methodology.QSAR study on para-substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices.Ligand-based virtual screening procedure for the prediction and the identification of novel β-amyloid aggregation inhibitors using Kohonen maps and Counterpropagation Artificial Neural Networks.Predictive QSAR workflow for the in silico identification and screening of novel HDAC inhibitors.Hydroxamic Acids Constitute a Novel Class of Autotaxin Inhibitors that Exhibit in Vivo Efficacy in a Pulmonary Fibrosis Model.A Risk Assessment Tool for the Virtual Screening of Metal Oxide Nanoparticles through Enalos InSilicoNano Platform.Editorial: Towards Open Access for Cheminformatics.A nanoinformatics decision support tool for the virtual screening of gold nanoparticle cellular association using protein corona fingerprintsQuantitative Nanostructure-Activity Relationship Models for the Risk Assessment of NanoMaterialsStability and binding effects of silver(I) complexes at lipoxygenase-1Antiproliferative novel isoxazoles: Modeling, virtual screening, synthesis, and bioactivity evaluationEditorialEnalos InSilicoNano platform: an online decision support tool for the design and virtual screening of nanoparticlesEditorial
P50
Q27162585-FC808746-BB44-405B-8735-BC813E8A8877Q28246874-4E416AF3-FA40-441B-A069-21DF837845F8Q28286849-2B7CE014-E3C3-4C7E-BD5C-81743EC16AECQ28294267-C89C59CB-801D-4146-A7DA-B746689B2CB6Q30558438-960B2252-5280-477C-9BA1-36130AE3D3F2Q33584492-4967C523-7347-4511-97BA-D1CAF433A9B8Q34740499-D44CE40A-0B5E-49A4-BFAB-E7C671089263Q37875142-D4E8D488-D8F4-4AD9-A0E7-AA5ECB4F1C63Q38962006-E7456D54-A6B4-4658-9ADC-2A3F04B118CFQ39112164-D09046FB-41DC-407A-8796-95FA2892CCD9Q39391532-4A1AAD93-6B4E-49CD-8EB6-F24EACA127F9Q41681901-5AAF0116-D000-4D70-90DD-D05254B14B68Q42228191-9EE96904-256D-453F-9C80-33A27B80DB49Q42696372-EA5B0DBE-AE25-4D36-B7FE-97AE15C39B27Q42713099-EAFC9378-D869-4B72-A72F-5AFD2724C284Q42868500-2C4580D5-19BF-4958-9167-815EC1D396F6Q44495412-8DB68011-1649-4620-86A7-C646BE6A540CQ45988637-4DE52A4C-21E9-4F93-AE79-B69EF49B3316Q46114582-599F102C-13F6-4521-AA97-5B3920AA02C8Q47806909-1674D4D0-4B55-4126-8B50-810521900BCAQ50054633-B42C2BCC-618E-4CFE-B647-AFFD1C07DE97Q50911540-42F52A32-8317-4756-BB15-7975893ED0F2Q51022402-71ED56FA-5966-4079-8AA0-F7C80BF5C1E3Q51172801-5904B3EC-4863-4A6A-9BD6-6CB898EDDC2EQ51178443-ED9C009F-FDF9-417D-8EA2-2741C1693659Q51189415-D285CE7E-7D46-4123-A2B4-1BCD6983B653Q51322617-0FED01F4-B9F6-46AB-BD84-E3BD51373CB6Q51341773-4EE1B6C8-D55A-4287-8C4D-3D02DC22BCA6Q51623698-546222B6-3AF0-4D1C-B742-EA5D4C789CF8Q51852400-407C9CAC-D65D-4CEA-A3AA-37637E92F44FQ52604839-1830B39D-0C4F-4DB9-8BB9-5DC4152155FBQ53495118-7D3E6ED0-7124-4603-9FAD-CDF66052A5C0Q54126058-974764A4-BA08-4988-BD55-DE6FA390C4D6Q56744549-0D4104A1-AE3D-462A-AFA9-279EEADC4D23Q57008587-615D5640-CB1F-4E13-9C63-4187FEC3CDC5Q57008595-D344DA8A-8528-4AAD-96D3-46B262CEC20DQ57008600-A527DC02-20FA-4881-BCB4-D698E4EF90CDQ57008604-C28B6AA2-2781-442C-AFA3-1A4953BB4FA2Q57008609-B3E51B7A-4C1C-4109-9A3F-5E593840409BQ57008616-410F625D-B051-47A7-B688-5ACE9E396DCB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Antreas Afantitis
@ast
Antreas Afantitis
@en
Antreas Afantitis
@es
Antreas Afantitis
@nl
type
label
Antreas Afantitis
@ast
Antreas Afantitis
@en
Antreas Afantitis
@es
Antreas Afantitis
@nl
prefLabel
Antreas Afantitis
@ast
Antreas Afantitis
@en
Antreas Afantitis
@es
Antreas Afantitis
@nl
P1053
A-9637-2010
P106
P1153
6507913243
P21
P2456
P31
P3829
P496
0000-0002-0977-8180